ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Shimadzu Corporation (PK)

Shimadzu Corporation (PK) (SHMZF)

27.08
0.00
(0.00%)
Closed March 23 4:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
27.08
Bid
23.83
Ask
29.85
Volume
-
0.00 Day's Range 0.00
22.52 52 Week Range 32.2083
Market Cap
Previous Close
27.08
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
250
Shares Outstanding
294,653,235
Dividend Yield
14,338.88%
PE Ratio
0.14
Earnings Per Share (EPS)
193.57
Revenue
511.9B
Net Profit
57.04B

About Shimadzu Corporation (PK)

Sector
Meas & Controlling Dev, Nec
Industry
Machinery/engineering Diverse
Headquarters
Kyoto, Kyoto, Jpn
Founded
1984
Shimadzu Corporation (PK) is listed in the Meas & Controlling Dev sector of the OTCMarkets with ticker SHMZF. The last closing price for Shimadzu (PK) was $27.08. Over the last year, Shimadzu (PK) shares have traded in a share price range of $ 22.52 to $ 32.2083.

Shimadzu (PK) currently has 294,653,235 shares outstanding. The market capitalization of Shimadzu (PK) is $7.98 billion. Shimadzu (PK) has a price to earnings ratio (PE ratio) of 0.14.

SHMZF Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10027.0827.0827.0800CS
40027.0827.0827.0825027.08CS
120027.0827.0827.0825027.08CS
264.5620.248667850822.5227.0822.5216627.08CS
522.0888.3546734955224.99232.208322.5218629.66679809CS
156-7.17-20.934306569334.2534.2522.525127030.61799334CS
2603.967817.167556528623.11224122.523218930.66511713CS

SHMZF - Frequently Asked Questions (FAQ)

What is the current Shimadzu (PK) share price?
The current share price of Shimadzu (PK) is $ 27.08
How many Shimadzu (PK) shares are in issue?
Shimadzu (PK) has 294,653,235 shares in issue
What is the market cap of Shimadzu (PK)?
The market capitalisation of Shimadzu (PK) is USD 7.98B
What is the 1 year trading range for Shimadzu (PK) share price?
Shimadzu (PK) has traded in the range of $ 22.52 to $ 32.2083 during the past year
What is the PE ratio of Shimadzu (PK)?
The price to earnings ratio of Shimadzu (PK) is 0.14
What is the cash to sales ratio of Shimadzu (PK)?
The cash to sales ratio of Shimadzu (PK) is 0.02
What is the reporting currency for Shimadzu (PK)?
Shimadzu (PK) reports financial results in JPY
What is the latest annual turnover for Shimadzu (PK)?
The latest annual turnover of Shimadzu (PK) is JPY 511.9B
What is the latest annual profit for Shimadzu (PK)?
The latest annual profit of Shimadzu (PK) is JPY 57.04B
What is the registered address of Shimadzu (PK)?
The registered address for Shimadzu (PK) is 1 NISHINOKYO-KUWABARA-CHO, NAKAGYO-KU, KYOTO, KYOTO, 604-8511
What is the Shimadzu (PK) website address?
The website address for Shimadzu (PK) is www.shimadzu.com
Which industry sector does Shimadzu (PK) operate in?
Shimadzu (PK) operates in the MACHINERY/ENGINEERING DIVERSE sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EGSEEvergreen Sustainable Enterprises Inc (CE)
$ 0.0008
(79,900.00%)
115
HLLPFHello Pal International Inc (CE)
$ 0.0005
(49,900.00%)
1,000
SBESSouth Beach Spirits Inc (CE)
$ 0.0002
(19,900.00%)
6M
BETSFBit Brother Ltd (CE)
$ 0.04
(13,233.33%)
140
RKFLRocketFuel Blockchain Inc (CE)
$ 0.01
(9,900.00%)
7k
ZMMHZhongMin Meihao Holding Company Ltd (CE)
$ 0.000001
(-99.98%)
225k
STTOSITO Mobile Ltd (CE)
$ 0.0004
(-99.76%)
278
LSDIFLucy Scientific Discovery Inc (CE)
$ 0.000001
(-99.50%)
1,000
INTKIndustrial Nanotech Inc (PK)
$ 0.000001
(-99.33%)
3.03M
NVOSNovo Integrated Sciences Inc (CE)
$ 0.0005
(-99.07%)
11.21k
KGKGKona Gold Beverage Inc (PK)
$ 0.0001
(-25.93%)
532.65M
ASIIAccredited Solutions Inc (PK)
$ 0.0005
(49.25%)
524.57M
HMBLHUMBL Inc (PK)
$ 0.0003
(0.00%)
284.16M
GTVHGolden Triangle Ventures Inc (PK)
$ 0.0006
(50.00%)
218.02M
TPTWTPT Global Tech Inc (PK)
$ 0.0002
(0.00%)
160.5M

Discussion

View Full Feed
fregata fregata 4 minutes ago
kthomp19 is paid common lunatic hater with LOW IQ LEVEL ,HAVING MENTAL RETARDATION .
FNMA
david444 david444 6 minutes ago
$TMSH 1.8B OS trip2 new CEO AI stock Pioneering human centric technologies. 5 entities in AI, mental wellness, performance analytics, sports/entertainment merging into $TMSH.

Acquired Mindwell Solutions Group LLC through new CEO Michael Berman. Here is Michael Berman's bio from Mindw
TMSH
$2.00 or no deal $2.00 or no deal 8 minutes ago
Nice...

Repeal the Mikah Tax -- To be paid by all shareholders at buyout
1. Cost of Second Tier Suitors
2. Cost of Secret Side Deal with Hakim
3. Cost of Mikah litigation
4. Cost of remaining OTC
ELTP
$2.00 or no deal $2.00 or no deal 9 minutes ago
All the BE studies failed last year.

Nasrat lied to us when said QUOTE "At least two ANDA's will be filed in 2024".

And he said one of these was the CNS product (Concerta).

I’d like Elite to expand their portfolio. The best way is having ANDA’s approved.
ELTP
$2.00 or no deal $2.00 or no deal 13 minutes ago
You mean Kirko...

Nasrat was all in years ago and deserves both the credit and the rewards for making this company a force in the generic drug field.
ELTP
Truenorth2016 Truenorth2016 19 minutes ago
Also Stervc, GCAN CEO Aitan keeps emphasizing in Core Gaming Pr's and the merger video, this:

"Core Gaming has developed cutting edge AI tools using text, language, image and video models to achieve a 50% boost in content production, reducing production time by over 40%, and significa
GCAN
Peter J Peter J 21 minutes ago
Well...HELLO mr fung derf...

LET'S WELCOME A NEW MEMBER TO THE ALTRUIST GANG... 🤣

However, my answer is, I don't care about what is posted if its not intended to hurt others
ERHE
Polymer Paul Polymer Paul 22 minutes ago
This is good.... So you now know that when Yves says 18-24 months for results... He means 18-24 months !!! Long time off that Belgium ... Very long time in the stock world. Good luck with that
LWLG
$2.00 or no deal $2.00 or no deal 23 minutes ago
EVERYONE CARES about what happened 10 years ago!

NO ONE CARES about what happened 10 years ago!
ELTP
$2.00 or no deal $2.00 or no deal 24 minutes ago
Agreed!

Hakim is a miserable failure when it comes to fulfilling his fiduciary duty to Elite shareholders.
ELTP
Peter J Peter J 24 minutes ago
Still posting, mr. 6503 posts? While having no financial interest here... 🤣
https://investorshub.advfn.com/boards/profileb.aspx?user=44043
ERHE
$2.00 or no deal $2.00 or no deal 24 minutes ago
He's been horrible.

Nasrat has been an amazing CEO for investors that have held their shares.
ELTP
Wayne R Wayne R 26 minutes ago
Last month was last month, this is this month and they just voted for another this month.

Sure, I know it is hard to keep track....
MULN
BDEZ BDEZ 35 minutes ago
LBJ Talks About Shooting Methamphetamine with Jackie Kennedy in Newly Released Presidential Phone Call

https://x.com/RealAlexJones/status/1903544281098330461
Truenorth2016 Truenorth2016 37 minutes ago
In Our Face Stervc!! NVDA and Core Gaming has the same tech and this is why GCAN CEO Aitan Zacharin keep saying his company is going to soon be the Number One "AI Gaming" Company in the world...... AITAN has something up his sleeve.....he knows he has tech that no one else has or has an edge on othe
GCAN NVDA
SkeBallLarry SkeBallLarry 38 minutes ago
Now there's a good one, Trin .. !!!
Investor2014 Investor2014 41 minutes ago
In the current context and considering Missling is from Europe, where approval is sought from EMA. Anavex have run only one tiny adult Rett trial in the U.S., all other trials have been run in countries collaborating with Europe. Considering all this - the Anavex HQ may not be in NYC or anywhere clo
AVXL
BDEZ BDEZ 48 minutes ago
Foreman was a prominent promoter of the jab. Even doing paid commercials

https://x.com/RealAlexJones/status/1903397708368404556
Flexplate Flexplate 53 minutes ago
Live Update At 09:18:06 EST: On Friday, March 21, 2025 TransCode Therapeutics Inc. stock [NASDAQ: RNAZ] is trending up by 34.42%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

TransCode Therapeutics received a nod to proc
RNAZ
cleanerworldwehope cleanerworldwehope 57 minutes ago
Scancell announces further positive data from the ongoing SCOPE trial of SCIB1 with double CPIs for Advanced
Melanoma
80% Progression Free Survival in 25 patients at 6 months
20% (5) patients have shown a complete response following treatment
Disease Control Rate of 84% a
MRNA
janice shell janice shell 58 minutes ago
I think perhaps he should report it to his carrier as phishing. That might make it go away. At least for a while.
Flexplate Flexplate 58 minutes ago
The amount of bullish sentiment on this is insane. One of the other chat pages I'm on has gained over 900 new followers on RNAZ since Fridays close. Monday this is going to run hard!
RNAZ
Investor2014 Investor2014 1 hour ago
You misunderstood Hoskuld’s sentence, go back, read and think.
AVXL